Boehringer Ingelheim

Boehringer backs $33M cancer vaccine play at Switzerland's AMAL Therapeutics
Endpoints
Mon, 11/12/18 - 09:39 am
vaccines
cancer vaccines
Boehringer Ingelheim
Amal Therapeutics
Switzerland
Boehringer Cites ‘Massive’ Number of Patents in Humira Biosimilar Suit
RAPS.org
Fri, 11/9/18 - 11:34 am
Boehringer Ingelheim
AbbVie
Humira
patents
biosimilars
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Mon, 10/22/18 - 05:17 pm
Europe
AbbVie
Humira
Amgen
Samsung Bioepis
Mylan Labs
Novartis
Sandoz
Fresenius Kabi
Boehringer Ingelheim
New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease
CP Wire
Wed, 10/10/18 - 10:13 am
Jardiance
Boehringer Ingelheim
Eli Lilly
diabetes
type 2 diabetes
New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease
Wed, 10/10/18 - 10:08 am
Jardiance
Boehringer Ingelheim
Eli Lilly
Lilly, Boehringer hit heart safety mark with Januvia rival Tradjenta. Is that enough?
Fierce Pharma
Fri, 10/5/18 - 08:51 pm
Boehringer Ingelheim
Eli Lilly
Tradjenta
diabetes
Boehringer Ingelheim joins the crowd and goes all-in on oncolytic viruses, buying ViraTherapeutics in $244M deal
Endpoints
Thu, 09/13/18 - 11:30 am
Boehringer Ingelheim
ViraTherapeutics
M&A
Cooperation agreement between Boehringer Ingelheim and Tsinghua University (Beijing)
GoinPharma
Tue, 09/11/18 - 11:32 pm
Boehringer Ingelheim
Tsinghua University
Boehringer Ingelheim and Tsinghua University Collaborate to Harness the Immune System to Better Fight Infectious Diseases
CP Wire
Tue, 09/4/18 - 10:09 am
antibiotics
Boehringer Ingelheim
drug development
Boehringer Ingelheim and Tsinghua University Collaborate to Harness the Immune System to Better Fight Infectious Diseases
Tue, 09/4/18 - 10:08 am
Boehringer Ingelheim
Boehringer, Lilly diabetes drug Tradjenta succeeds in cardiovascular outcome trial
Pharmaceutical Business Review
Sun, 08/26/18 - 12:00 pm
Boehringer Ingelheim
Eli Lilly
clinical trials
diabetes
Tradjenta
Boehringer Ingelheim lands option on cystic fibrosis gene therapy
Fierce Biotech
Mon, 08/6/18 - 09:58 am
Boehringer Ingelheim
cystic fibrosis
Oxford BioMedica
gene therapy
Trajenta Meets Primary Endpoint in Cardiovascular Trial
CP Wire
Thu, 07/19/18 - 09:47 am
Boehringer Ingelheim
Eli Lilly
Trajenta
Trajenta Meets Primary Endpoint in Cardiovascular Trial
Thu, 07/19/18 - 09:47 am
Boehringer Ingelheim
Eli Lilly
Trajenta
Boehringer Ingelheim Licenses Novel TCRm Antibody for Cancer Treatment
CP Wire
Tue, 07/17/18 - 09:56 am
Boehringer Ingelheim
Eureka Therapeutics
monoclonal antibodies
Boehringer Ingelheim Licenses Novel TCRm Antibody for Cancer Treatment
Tue, 07/17/18 - 09:52 am
Boehringer Ingelheim
Eureka Therapeutics
monoclonal antibodies
According to new market survey, pharma industry continues to invest heavily on basic research
GoinPharma
Thu, 07/12/18 - 09:22 am
R&D
Boehringer Ingelheim
Boehringer Ingelheim Invests More Than $230 Million in Veterinary Public Health Production Center in Europe's “Vaccine Valley”
CP Wire
Tue, 07/10/18 - 11:13 am
Boehringer Ingelheim
animal health
Europe
Boehringer Ingelheim Invests More Than $230 Million in Veterinary Public Health Production Center in Europe's “Vaccine Valley”
Tue, 07/10/18 - 09:42 am
Boehringer Ingelheim
Boehringer Ingelheim BioXcellence adds fill-finish line to China plant
Fierce Pharma
Fri, 07/6/18 - 10:33 pm
Boehringer Ingelheim
China
drug manufacturing
biologics

Pages